| ELTX Shares Outstanding History Table | ||||||||||||||||||||
Below is a table of the ELTX shares outstanding history going back to 5/10/2024:
Also see: ELTX Market Cap History ELTX YTD Return |
ELTX Shares Outstanding History — Elicio Therapeutics Share Count Over Time
As of 5/8/2026 Elicio Therapeutics has 19.09 million ELTX shares outstanding. Investors often track the ELTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ELTX share count trends over time, with 9 historical shares outstanding datapoints presented, dating back to 5/10/2024.
| ELTX Shares Outstanding History Chart | |||||||||||||||||||||
ELTX Historical Shares Outstanding: +36.44% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||
| ELTX Stock Price Chart |
| About Elicio Therapeutics Inc |
| Elicio Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing a pipeline of immunotherapies for the treatment of cancer. Co. provides a platform, amphiphile (AMP) that delivers immuno therapeutics directly to the lymph nodes (brain center) of the immune system. Co.'s lead product candidate, ELI-002, is being developed to treat cancers driven by kirsten rat sarcoma (KRAS). It is conducting a Phase I/II clinical trial of ELI-002 (AMPLIFY-201). We show 9 historical shares outstanding datapoints in our coverage of ELTX's shares outstanding history. Understanding the changing numbers of ELTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELTX by allowing them to research ELTX shares outstanding history as well as any other stock in our coverage universe. |
| ELTX Current Stock Quote |
Quotes delayed 20 minutes  Free ELTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ELTX Share Performance |
| Shares Outstanding Peers |
| Elicio Therapeutics (ELTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ELUT Shares Outstanding History ELVN Shares Outstanding History ELYM Shares Outstanding History EMBC Shares Outstanding History EMMA Shares Outstanding History ENDP Shares Outstanding History ENOB Shares Outstanding History ENOV Shares Outstanding History ENSC Shares Outstanding History ENSG Shares Outstanding History More Healthcare companies » |
ELTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
